Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial

INTRODUCTION: Limited prospective evidence is available to guide selection of first-line maintenance therapy in patients with COPD. This pre-specified analysis of the EMAX trial explored the efficacy and safety of dual- versus mono-bronchodilator therapy in maintenance-naïve and maintenance-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjermer, Leif, Boucot, Isabelle H, Maltais, François, Kerwin, Edward M, Naya, Ian P, Tombs, Lee, Jones, Paul W, Compton, Chris, Lipson, David A, Vogelmeier, Claus F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254100/
https://www.ncbi.nlm.nih.gov/pubmed/34234425
http://dx.doi.org/10.2147/COPD.S291751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254100/
https://www.ncbi.nlm.nih.gov/pubmed/34234425
http://dx.doi.org/10.2147/COPD.S291751

Ejemplares similares